R26Q (p.Arg26Gln) variant of AGT (Angiotensinogen)

R26Q (p.Arg26Gln) in AGT (Angiotensinogen) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Renal tubular dysgenesis. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data and structural context.

R26Q (p.Arg26Gln) variant details